News
CTEV
27.28
+13.67%
3.28
Claritev price target raised to $47 from $43 at Canaccord
TipRanks · 6h ago
Claritev (CTEV) Receives a Buy from Guggenheim
TipRanks · 11h ago
Canaccord Genuity Sticks to Their Buy Rating for Claritev (CTEV)
TipRanks · 11h ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Claritev (CTEV), Aldeyra Therapeutics (ALDX) and Argenx Se (ARGX)
TipRanks · 12h ago
Claritev Corp (CTEV) Q3 2026 Earnings Call Transcript
The Motley Fool · 1d ago
Claritev Q3 2026 Earnings Call Transcript
Benzinga · 1d ago
Claritev Corporation Reports Q3 2026 Revenues of $268.3 million and Updates full-year 2026 guidance
NASDAQ · 1d ago
Claritev Raises FY2026 Sales Guidance from $1.000B-$1.020B to $1.038B-$1.043B vs $1.014B Est
Benzinga · 1d ago
Claritev Corporation (CTEV) Reports Q3 Loss, Tops Revenue Estimates
NASDAQ · 1d ago
Claritev raises FY26 revenue view to $1.038B-$1.043B from $1B-$1.02B
TipRanks · 1d ago
Claritev GAAP EPS of -$3.64 misses by $0.01, revenue of $268.3M beats by $12.17M
Seeking Alpha · 1d ago
Claritev Corporation Q3 Loss Decreases
NASDAQ · 1d ago
*Claritev Sees FY26 Rev $1.038B-$1.043B >CTEV
Dow Jones · 1d ago
Press Release: Claritev Corporation Reports Third -3-
Dow Jones · 1d ago
Press Release: Claritev Corporation Reports Third -4-
Dow Jones · 1d ago
Press Release: Claritev Corporation Reports Third Quarter 2026 Results
Dow Jones · 1d ago
Weekly Report: what happened at CTEV last week (1102-1106)?
Weekly Report · 1d ago
Here are the major earnings before the open Monday
Seeking Alpha · 2d ago
Claritev Q3 2026 Earnings Preview
Seeking Alpha · 4d ago
Claritev's Transformation Bet Collides With a Balance Sheet That Hasn't Turned Yet
Barchart · 4d ago
More
Webull provides a variety of real-time CTEV stock news. You can receive the latest news about Claritev Corp through multiple platforms. This information may help you make smarter investment decisions.
About CTEV
Claritev Corp, formerly MultiPlan Corporation, is a healthcare technology, data and insights company. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The Company uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. It uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. It provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.